Assessment of the Treatment Regimen, Part 3 Steve V. Edelman, MD Robert R. Henry, MD Self-Monitoring of Blood Glucose (SMBG) Systems A combination of factors affect the overall performance of SMBG systems…
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 13-Pt 4
Assessment of the Treatment Regimen, Part 4 Steve V. Edelman, MD Robert R. Henry, MD Applying SMBG Results to Adjust Insulin Doses Patients can be taught how to analyze and use SMBG data to effectively make adjustments in their insulin doses so that they can maintain and improve glycemic control…. …
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 14, Pt1
Acute Complications: Metabolic – DKA Steve V. Edelman, MD Robert R. Henry, MD The most common acute complications of diabetes are metabolic problems (DKA, HHNS, hypoglycemia) and infection. In addition, the quality of life of patients with chronic and severe hypoglycemia is adversely affected. Characteristic symptoms of tiredness and lethargy …
Read More »Diagnosis and Management of Type 2 Diabetes, Tenth Edition, Ch 9, Pt 2
Selecting an Insulin Preparation, Chapter 9 – Part 2 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego There are three types of insulin: animal, …
Read More »Diagnosis and Management of Type 2 Diabetes, Tenth Edition, Ch 9, Pt 3
Application of Intensive Insulin Therapy, Chapter 9 – Part 3 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego The goals of therapy …
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 9-Pt 4
Combination Therapy, Chapter 9 – Part 4 Steve V. Edelman, MD Robert R. Henry, MD Combination therapy usually refers to the use of oral antidiabetic agents (daytime) together with a single injection of intermediate-acting or long-acting insulin at bedtime. The rationale for using an evening-insulin strategy is based on the …
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 9-Pt 5
Multiple-Injection Regimens, Chapter 9 – Part 5 Steve V. Edelman, MD Robert R. Henry, MD One of the more common insulin regimens utilized in Type 2 diabetes mellitus is a split-mixed regimen consisting of a prebreakfast and predinner dose of an intermediate- and a fast-acting insulin. This split-mixed regimen of …
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 9-Pt 6
Insulin-Pump Therapy + New Types of Insulin Preparations + Complications of Insulin Therapy, Chapter 9 – Part 6 Steve V. Edelman, MD Robert R. Henry, MD Insulin-Pump Therapy Insulin-pump therapy has been traditionally used for people with Type 1 diabetes. People with Type 1 diabetes usually do not have insulin …
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 11-Pt 1
Pramlintide Therapy, Chapter 11 – Part 1 Steve V. Edelman, MD Robert R. Henry, MD The discovery of insulin over 80 years ago is one of the great success stories in the history of modern medicine. Although insulin remains the mainstay of therapy for many patients with diabetes, the greatest …
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 11-Pt 2
Pramlintide Therapy Steve V. Edelman, MD Robert R. Henry, MD Mechanisms of Action: Gastric Emptying In healthy individuals, amylin modulates the rate of gastric emptying, most likely via the vagus nerve, to regulate the inflow of nutrients into the small intestine and thereby reduce the postprandial rise in glucose.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.